BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 27793376)

  • 1. Combined hormonal contraception and the risk of venous thromboembolism: a guideline.
    ;
    Fertil Steril; 2017 Jan; 107(1):43-51. PubMed ID: 27793376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal contraception and thrombosis.
    Sitruk-Ware R
    Fertil Steril; 2016 Nov; 106(6):1289-1294. PubMed ID: 27678035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
    Plu-Bureau G; Horellou MH; Gompel A; Conard J
    Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in women taking hormonal contraceptives.
    Blanco-Molina A; Monreal M
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Venous thromboembolism and oral contraception].
    Veljković M; Popovć J
    Med Pregl; 2010; 63(5-6):376-9. PubMed ID: 21186550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
    Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
    Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
    Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
    J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestin-only contraception and venous thromboembolism.
    Blanco-Molina MA; Lozano M; Cano A; Cristobal I; Pallardo LP; Lete I
    Thromb Res; 2012 May; 129(5):e257-62. PubMed ID: 22425318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraception in women with mild thrombophilia: what have we learned recently?
    Blanco-Molina Á
    Thromb Res; 2012 Oct; 130 Suppl 1():S16-8. PubMed ID: 23026651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and prognosis of thromboembolism associated with oral contraceptives: Age-dependent difference in Japanese population.
    Sugiura K; Ojima T; Urano T; Kobayashi T
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1766-1772. PubMed ID: 29998477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.
    Parks AL; Auerbach AD; Schnipper JL; Anstey JE; Sterken DG; Hecht TEH; Fang MC;
    Thromb Res; 2020 Dec; 196():355-358. PubMed ID: 32977136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O; Spinar J; Musil V; Pozdísek Z
    Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism in women: a specific reproductive health risk.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2013; 19(5):471-82. PubMed ID: 23825156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
    Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk?
    Han L; Jensen JT
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):683-98. PubMed ID: 26598309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diffuse symptoms in young women may indicate venous thromboembolism. Important to ask about the use of combined hormonal contraception].
    Milsom I; von Sydow H; Thörn AB; Björkelund C; Odlind V
    Lakartidningen; 2012 Sep 19-26; 109(38):1680-2. PubMed ID: 23094400
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulation strategies for venous thromboembolism: moving towards a personalised approach.
    Black SA; Cohen AT
    Thromb Haemost; 2015 Oct; 114(4):660-9. PubMed ID: 26084864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulodexide for the extended treatment of venous thromboembolism.
    Walenga JM; Fareed J; Ramacciotti E
    Int Angiol; 2016 Dec; 35(6):531-533. PubMed ID: 27680735
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.